Australian crop development agencies have been forced to abandon their claims on two chickpea varieties they admit were obtained from an international public research institute based in India (see RAFI's release of 6 January). In a blunt message sent January 8th, the institute, the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) - acting on information from RAFI - demanded that the claims for Australian Plant Breeders' Rights (a patent-like intellectual property regime for crop varieties) be dropped. On January 16th, the two Australian institutes - Agriculture WA and CLIMA - said that the claims had been abandoned.
News & blogs
The Australian seed industry has applied for plant breeder's rights (PBR) on two chickpea varieties taken from ICRISAT (International Crops Research Institute for the Semi-Arid Tropics) - an internationally-funded public research centre based in Hyderabad, India. If granted, the Australians will give themselves a 20 year monopoly on the Asian chickpeas, which they propose to market in South Asia and the Middle East. Neither variety, however, is new to farmers. In fact, both are ICRISAT accessions originating in farmer's fields in Iran and India. It's blatant biopiracy," explains Farhad Mazhar of Bangladeshi organization UBINIG and the South Asian Network on Food, Ecology, and Culture, "Australia is privatizing seeds that belong to our farmers, and they plan to sell them back to us with their own self-authorized plant monopoly."
NSF Sidesteps Own Report to Fund Controversial Project to Collect the Blood of Indigenous Peoples Around the World. International Controls Needed.
A US National Research Council (NRC) report released October 21 has unambiguously rebuffed the controversy-plagued Human Genome Diversity Project (HGDP), a project that proposed to collect DNA samples from over 700 groups of people - mostly indigenous communities - from around the world.
After months of indecision and confusing signals, the US National Institutes of Health (NIH) has finally put an end to its internationally-denounced patent on the human cell line of a Hagahai indigenous person from Papua New Guinea. I hope this is the end of what is arguably the most offensive patent ever issued." says Alejandro Argumedo of the Canada-based Indigenous Peoples' Biodiversity Network (IPBN).
It is more than a year since the Dag Hammarskjöld Seminar at Bogève and in Geneva. We have tried our best to retain the spirit of those important discussions while updating the information. The pace of technical, political and corporate change makes both the data and the analysis something of a moving target. No doubt we have sometimes missed our mark.